The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease

The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease

Zobrazit další vydání (1)

Oral bisphosphonates (oBP) are contraindicated in patients with severe chronic kidney disease (CKD), but there is a lack of data on safety in this area. We aimed to study the association between oBP use and risk of acute kidney injury (AKI), gastrointestinal events (GIE) and hypocalcaemia (HC) in pa...

Podrobná bibliografie
Hlavní autoři:	Robinson, D, Ali, M, Pallares, N, Tebe, C, Cooper, C, Abrahamsen, B, Caskey, F, Ben-Shlomo, Y, Judge, A, Javaid, M, Diez-Perez, A, Prieto-Alhambra, D
Médium:	Conference item
Vydáno:	Springer London 2018

Podobné jednotky

The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease
Autor: Ali, M, a další
Vydáno: (2018)

Oral bisphosphonate use and risk of acute kidney injury, gastrointestinal events and hypocalcaemia in patients with moderate-advanced chronic kidney disease: a population-based cohort study
Autor: Ali, MS, a další
Vydáno: (2017)

Oral bisphosphonates and chronic kidney disease: progression and safety
Autor: Prieto-Alhambra, D, a další
Vydáno: (2018)

Oral bisphosphonate use and all‐cause mortality in patients with advanced (stage IIIB+) chronic kidney disease: a propensity score analysis
Autor: Alarkawi, D, a další
Vydáno: (2018)

Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a binational cohort analysis
Autor: Robinson, DE, a další
Vydáno: (2021)

Oral bisphosphonate use and latent class trajectories of kidney function: A cohort study
Autor: Strauss, V, a další
Vydáno: (2018)

Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
Autor: Robinson, DE, a další
Vydáno: (2021)

Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
Autor: Robinson, DE, a další
Vydáno: (2021)

Oral bisphosphonate use and all-cause mortality in patients with advanced (stage IIIB plus ) chronic kidney disease: a population-based cohort study
Autor: Alarkawi, D, a další
Vydáno: (2017)

Use of oral bisphosphonates and bone mineral density changes in moderate-severe (Stage 3B+) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, Denmark
Autor: Ali, M, a další
Vydáno: (2017)

Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
Autor: Danielle E Robinson, a další
Vydáno: (2021-03-01)

Bisphosphonate induced hypocalcaemia – report of six cases and review of the literature
Autor: Veronika Kreutle, a další
Vydáno: (2014-06-01)

Predictors of second fracture while on treatment with oral bisphosphonates: a multinational cohort study
Autor: Hawley, S, a další
Vydáno: (2014)

Denosumab-Induced Severe Hypocalcaemia in Chronic Kidney Disease
Autor: Ryan Jalleh, a další
Vydáno: (2018-01-01)

Denosumab and chronic kidney disease: Severe life-threatening hypocalcaemia
Autor: Pilar Monge Rafael, a další
Vydáno: (2018-01-01)

Predictors of fracture while on treatment with oral bisphosphonates: a population-based cohort study.
Autor: Prieto-Alhambra, D, a další
Vydáno: (2014)

Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B–5) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, Denmark
Autor: Ali, MS, a další
Vydáno: (2020)

Patients With atypical femur fractures have the same mortality as the background population--drug-dhanneling bias, bisphosphonate effects, and public health implications
Autor: Abrahamsen, B, a další
Vydáno: (2016)

BISPHOSPHONATE USE IS ASSOCIATED WITH REDUCED REVISIONS OF LOWER LIMB JOINT (KNEE OR HIP) ARTHROPLASTY: A POPULATION-BASED COHORT STUDY
Autor: Prieto-Alhambra, D, a další
Vydáno: (2011)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study.
Autor: Prieto-Alhambra, D, a další
Vydáno: (2011)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study.
Autor: Prieto-Alhambra, D, a další
Vydáno: (2011)

Bisphosphonate use and risk of severe acute kidney injury: a self-controlled case series in frail elderly patients in the UK
Autor: Oda, T, a další
Vydáno: (2021)

A PREDICTIVE TOOL FOR ORAL BISPHOSPHONATE THERAPY DISCONTINUATION WITHIN INCIDENT USERS: A POPULATION-BASED COHORT STUDY
Autor: Round, G, a další
Vydáno: (2012)

PREDICTORS OF INADEQUATE RESPONSE TO ORAL BISPHOSPHONATE THERAPY: A POPULATION-BASED COHORT STUDY
Autor: Round, G, a další
Vydáno: (2012)

The association between calcium ± vitamin D supplementation and fracture risk among incident users of oral bisphosphonates: a population-based cohort study
Autor: Reyes, C, a další
Vydáno: (2015)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: Population based retrospective cohort study
Autor: Prieto-Alhambra, D, a další
Vydáno: (2012)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: Population based retrospective cohort study
Autor: Prieto-Alhambra, D, a další
Vydáno: (2012)

Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion
Autor: Jean-Jacques Body, a další
Vydáno: (2018-09-01)

Fracture risk before and after total hip replacement in patients with osteoarthritis: potential benefits of bisphosphonate use.
Autor: Prieto-Alhambra, D, a další
Vydáno: (2011)

Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: A propensity score analysis
Autor: Prieto-Alhambra, D, a další
Vydáno: (2011)

Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: a propensity score analysis.
Autor: Prieto-Alhambra, D, a další
Vydáno: (2011)

Oral bisphosphonate use reduces cardiovascular events in a cohort of Danish patients referred for bone mineral density
Autor: Rodriguez, AJ, a další
Vydáno: (2020)

Impact of bisphosphonates in age-related macular degeneration: Retrospective cohort and nested case-control study
Autor: Garriga, C, a další
Vydáno: (2018)

Oral bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
Autor: Garriga, C, a další
Vydáno: (2018)

Impact of bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
Autor: Garriga, C, a další
Vydáno: (2018)

Bisphosphonates and Age-Related Macular Degeneration: A Propensity-Matched Cohort and Nested Case-Control Analysis
Autor: Garriga, C, a další
Vydáno: (2017)

Vitamin D repletion and aromatase inhibitor-related bone loss in women non treated with bisphosphonates
Autor: Prieto-Alhambra, D, a další
Vydáno: (2011)

Predicting imminent fractures in patients with a recent fracture or starting oral bisphosphonate therapy: development and international validation of prognostic models
Autor: Khalid, S, a další
Vydáno: (2021)

HYPOCALCAEMIA – CASE REPORT
Autor: Tina Svetlik, a další
Vydáno: (2022-03-01)

Pseudohypoparathyroidism, Rare Cause of Hypocalcaemia!
Autor: Rupal V. Dosi, a další
Vydáno: (2013-10-01)